<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>: iStockAnalyst.com  Symbols Feed</title>
    <link>http://www.istockanalyst.com</link>
    <description>Custom RSS Feed</description>
    <generator>http://www.iStockAnalyst.com</generator>
    <pubDate>Mon, 09 Nov 2009 04:03:06 GMT</pubDate>
    <language>en</language>
    <ttl>30</ttl>
    <item>
      <title>Biostar Raises $3.6 Million</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614366</guid>
      <description><![CDATA[Biostar Pharmaceuticals has completed a private placement that raised $3.6 million in new capital. Biostar will use the proceeds to complete its new raw materials processing facility. By taking its raw material production in house, Biostar will lower costs and ensure its product quality. Biostar plans to sell excess raw materials to other pharmaceutical companies in the Shaanxi province.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614366>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 17:26:18 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BSPM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614366</link>
    </item>
    <item>
      <title>Bulls Back On Track?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614255</guid>
      <description><![CDATA[Good morning. With chants of &quot;Dow 10K… Dow 10K&quot; once again rising from the streets at the corner of Broad and Wall yesterday, it is easy to believe that the bulls are back on track and that we'll soon be looking at new highs for the stock market. And when reviewing the data inputs to yesterday's 204 point romp, it is also easy to don the Dow10K hat once again and join in on the celebration.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614255>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 16:21:18 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CSCO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614255</link>
    </item>
    <item>
      <title>Ford's Main Problem: The UAW's Crippling Job Classifications And Work Rules</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614051</guid>
      <description><![CDATA[Ford's 2,215 page 2007 master contract with the UAW 
1941 UAW-Ford contract<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614051>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 13:52:50 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">F</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614051</link>
    </item>
    <item>
      <title>Your Kind of Day?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3611831</guid>
      <description><![CDATA[As a rule, I try not to read too terribly much into a &quot;Fed Day&quot; as there is usually a big batch of volatility that may or may not mean much of anything come the dawn of the next day. Maybe, it's just me. Or maybe there are others that find themselves inclined to simply stand aside and watch the nuttiness from the sidelines on &quot;Fed Days.&quot; But in any event, the volatility after a Fed announcement, while fun to watch, may not be telling as to what to expect in the future.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3611831>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 19:06:48 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CSCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TGT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3611831</link>
    </item>
    <item>
      <title>The Dollar-Proof Portfolio</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3611744</guid>
      <description><![CDATA[Don't put off this important piece of the financial-planning process.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3611744>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 17:31:14 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CEW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GLD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IEO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MON</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">STPZ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">UDN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VEU</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VSS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VTI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WIP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3611744</link>
    </item>
    <item>
      <title>What Investors Should Look for In Today’s Fed Statement</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3605772</guid>
      <description><![CDATA[In its continuing efforts to nurture the fragile economic recovery, the U.S. Federal Reserve is widely expected to leave interest rates at record lows when it concludes its meeting today (Wednesday).<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3605772>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 13:04:24 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BCS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ING</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3605772</link>
    </item>
    <item>
      <title>Are Discount Brokers Shares Worth Owning?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3604683</guid>
      <description><![CDATA[The third quarter was a favorable one for the longs. Except for a few short-lived, minor pullbacks stock prices moved higher through the quarter. Stock price volatility declined, takeover activity rose, and risk appetite improved to help the S&amp;P gain 15%.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3604683>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 01:28:03 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMTD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ETFC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SCHB</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3604683</link>
    </item>
    <item>
      <title>Technology Rises And Buying Facebook</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3601987</guid>
      <description><![CDATA[Technology stocks have done well this year. The Technology Select Sector SPDR (XLK) bottomed out in March and by late October was up more than 60%.&#160;&#160; Tech has performed better than any other sector year-to-date – up 33.7% as of Friday’s close.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3601987>[More...]</a>]]></description>
      <pubDate>Tue, 03 Nov 2009 16:54:11 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBAY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GOOG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MA</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3601987</link>
    </item>
    <item>
      <title>Buffett Gets His Cheque Book Out</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3601899</guid>
      <description><![CDATA[Given the slew of positive economic data Monday you might have been forgiven for expecting a decent rebound in risk assets. There was a rebound of sorts in early New York trading, with the Dow up close to 150 points at one stage.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3601899>[More...]</a>]]></description>
      <pubDate>Tue, 03 Nov 2009 16:17:34 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BNI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">F</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GOOG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">INTC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3601899</link>
    </item>
    <item>
      <title>Five Ways To Ride The Commodities Bull</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3601726</guid>
      <description><![CDATA[Commodity prices have faltered in the last couple of weeks, and much of the “smart money” is saying the boom is over.
Don’t believe it.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3601726>[More...]</a>]]></description>
      <pubDate>Tue, 03 Nov 2009 15:21:07 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">VALE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3601726</link>
    </item>
    <item>
      <title>Business events scheduled for the coming week</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3615121</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;NEW YORK - Deadline for submitting a revised agreement in the battle over Google Inc.'s effort to get digital rights to millions of out-of-print books.&lt;/li&gt;&lt;li&gt;REDWOOD CITY, Calif. - Electronic Arts Inc. releases second-quarter financial results.&lt;/li&gt;&lt;li&gt;LOS ANGELES - Live Nation Inc. releases third-quarter financial results.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3615121>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 18:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ANF</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BZH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DISH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ERTS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FRE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GOOG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JCP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JWN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KBH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LEE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LYV</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">M</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MBI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TKTM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WMT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3615121</link>
    </item>
    <item>
      <title>Targacept has profit in quarter: Large milestone payment by AstraZeneca credited for first profit in almost three years</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3613879</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Nov. 6--Targacept Inc. posted its first quarterly profit in nearly three years yesterday, bolstered in large part by a $10 million milestone payment by AstraZeneca PLC. &lt;/li&gt;&lt;li&gt;Targacept, based in Piedmont Triad Research Park in Winston-Salem, is developing drugs based on nicotine research to treat diseases of the central nervous system. &lt;/li&gt;&lt;li&gt;The payment was the result of Targacept's research in adult attention deficit/hyperactivity disorder involving its AZD3480 drug compound, also known as TC-1734.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3613879>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 11:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TRGT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3613879</link>
    </item>
    <item>
      <title>DirecTV shows subscriber gains, as rivals see loss</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3612361</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Satellite TV operator DirecTV Group Inc. was one of the few pay-TV companies to gain subscribers in the third quarter, though earnings stayed steady because of the higher costs it incurred attracting and serving those new customers.&lt;/li&gt;&lt;li&gt;DirecTV said Thursday that a marketing partnership with AT&amp;T Inc. that began in February accounted for most of the increase in U.S. subscribers, but it likely also retained subscribers and gained new ones because of a perennial favorite, the NFL Sunday Ticket package that airs out-of-market games to football fans.&lt;/li&gt;&lt;li&gt;DirecTV, which is controlled by media mogul John Malone's Liberty Media Corp., has focused on attracting consumers who don't mind paying more for quality TV as long as they get football and other packages they want.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3612361>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 22:51:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CMCSA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DISH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LCAPA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">T</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TWC</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3612361</link>
    </item>
    <item>
      <title>DirecTV shows subscriber gains, as rivals see loss</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3611926</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Satellite TV operator DirecTV Group Inc. was one of the few pay-TV companies to gain subscribers in the third quarter, though earnings stayed steady because of the higher costs it incurred attracting and serving those new customers.&lt;/li&gt;&lt;li&gt;DirecTV said Thursday that a marketing partnership with AT&amp;T Inc. that began in February accounted for most of the increase in U.S. subscribers, but it likely also retained subscribers and gained new ones because of a perennial favorite, the NFL Sunday Ticket package that airs out-of-market games to football fans.&lt;/li&gt;&lt;li&gt;DirecTV, which is controlled by media mogul John Malone's Liberty Media Corp., has focused on attracting consumers who don't mind paying more for quality TV as long as they get football and other packages they want.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3611926>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 19:51:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CMCSA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DISH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LCAPA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">T</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TWC</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3611926</link>
    </item>
    <item>
      <title>AstraZeneca Q3 Net Income Up</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3592781</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;AstraZeneca, a UK-based pharmaceutical company, has reported a net income of $2.12 billion, or $1.46 per diluted share, for the third quarter ended September 30, 2009, compared to $1.74 billion, or $1.19 per diluted share, for the third quarter ended September 30, 2008.&lt;/li&gt;&lt;li&gt;Net income for the nine months ended September 30, 2009 was $5.98 billion, or $4.12 per diluted share, compared to $4.88 billion, or $3.33 per share, for the nine months ended September 30, 2008. &lt;/li&gt;&lt;li&gt;Total revenues were $23.86 billion for the nine months ended September 30, 2009, compared to $23.41 billion, for the prior-year period.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3592781>[More...]</a>]]></description>
      <pubDate>Fri, 30 Oct 2009 10:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3592781</link>
    </item>
    <item>
      <title>Hospira Profits Strong on Improved Efficiencies, Generic Drug Launch</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3583452</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Oct. 27--Hospital products maker Hospira Inc. this morning reported a 42 percent increase in third-quarter profits on strong sales and improved manufacturing efficiencies from an ongoing company-wide reorganization and cost-reduction plan. &lt;/li&gt;&lt;li&gt;That compares to $81.8 million, or 51 cents a share in the year-ago quarter. &lt;/li&gt;&lt;li&gt;Results were also buoyed by the launch of a generic colon cancer treatment the company introduced.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3583452>[More...]</a>]]></description>
      <pubDate>Tue, 27 Oct 2009 19:49:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">HSP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3583452</link>
    </item>
    <item>
      <title>Earnings Preview: Bristol-Myers 3Q earnings report</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3568342</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;NEW YORK - Bristol-Myers Squibb Co., the world's No. &lt;/li&gt;&lt;li&gt;The following is a summary of key developments and analyst opinion related to the period.&lt;/li&gt;&lt;li&gt;OVERVIEW: Growing competition for its top drugs threatens revenue for the maker of blood thinner Plavix, the world's second-bestselling medication, and psychiatric drug Abilify.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3568342>[More...]</a>]]></description>
      <pubDate>Wed, 21 Oct 2009 15:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3568342</link>
    </item>
    <item>
      <title>Drug makers, CVS slammed for promos</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3560042</guid>
      <description><![CDATA[Drug makers, CVS slammed for promos<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3560042>[More...]</a>]]></description>
      <pubDate>Sun, 18 Oct 2009 21:42:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3560042</link>
    </item>
    <item>
      <title>Business Highlights</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3558392</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Bank of America loses $2.24B as loan losses rise&lt;/li&gt;&lt;li&gt;CHARLOTTE, N.C. (AP) - Bank of America Corp. said Friday it lost more than $2.2 billion in the third quarter as loan losses kept rising, providing more evidence that consumers are still struggling to pay their bills.&lt;/li&gt;&lt;li&gt;The bank's total allowance for loan and lease losses now totals $35.83 billion.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3558392>[More...]</a>]]></description>
      <pubDate>Fri, 16 Oct 2009 22:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GOOG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WMT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3558392</link>
    </item>
    <item>
      <title>Dampier Defends Woodford Income Strategy</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3556374</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Hargreaves Lansdown head of research Mark Dampier has defended Invesco Perpetual UK equity income guru Neil Woodford's performance, and says now is the best time to invest.&lt;/li&gt;&lt;li&gt;Woodford's pound 6.4bn income and pound 8.6bn higher-income funds are 17th and 18th respectively in the UK equity income and growth sector from January 1 to September 25, according to figures from Lipper.&lt;/li&gt;&lt;li&gt;However, Dampier says this is due to the manager's long-term, bearish economic outlook and stocks that match this view - namely those with strong balance sheets and stable business models such as AstraZeneca and GlaxoSmithKline.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3556374>[More...]</a>]]></description>
      <pubDate>Thu, 15 Oct 2009 09:51:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3556374</link>
    </item>
    <item>
      <title>DRA Advisors LLC announces the sale of its remaining interest in the PL Retail Portfolio</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3609088</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;DRA Advisors LLC has announced that it has completed the sale of an 85%   interest in PL Retail LLC to Kimco Realty Corporation for a price of   $825 million. &lt;/li&gt;&lt;li&gt;PL Retail LLC is the joint venture entity that owns the   remaining 21 shopping centers acquired in the privatization of Price   Legacy Corporation in December, 2004. &lt;/li&gt;&lt;li&gt;Commenting on the sale, David   Luski, Chief Executive Officer of DRA stated: &quot;While we are pleased with   both the operating performance of the underlying assets of PL Retail and   our relationship with Kimco, the sale is consistent with the anticipated   ownership period of these properties and the strategy of our managed   Funds.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3609088>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 04:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KIM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3609088</link>
    </item>
    <item>
      <title>Kimco Realty Corporation announces acquisition of remaining interest in 21 properties in PL Retail portfolio</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3608111</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Kimco Realty Corporation announced today that it has completed the   purchase of the remaining 85 percent interest in PL Retail LLC, an   entity comprising 21 shopping centers that the company manages and in   which the company previously held a 15 percent interest. &lt;/li&gt;&lt;li&gt;The company funded the acquisition from its existing   credit facility.&lt;/li&gt;&lt;li&gt;The 21 shopping centers comprising approximately 5.2 million square feet   of gross leasable area (GLA) are located in California (8 assets; 27% of   GLA), Florida (6 assets; 42% of GLA), Phoenix AZ metro area (2 assets;   7.3% of GLA), metro NJ (2), Long Island, NY (1), metro Washington DC (1)   and Greenville, SC (1).&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3608111>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 21:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KIM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PETM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3608111</link>
    </item>
    <item>
      <title>Kimco Realty Corporation Announces Third Quarter 2009 Results; Declares Quarterly Dividend</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3608114</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Highlights for the third quarter   2009&lt;/li&gt;&lt;li&gt;Net income to common shareholders including non-cash impairments   and charges for the acceleration of deferred costs from early debt   repayment was $28.3 million or $0.07 per diluted share for the third   quarter of 2009 compared to $96.8 million or $0.37 per diluted share for   the third quarter of 2008.&lt;/li&gt;&lt;li&gt;Not all of these factors are determinable at this time and actual results may vary from the projected results, and may be above or below the range indicated.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3608114>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 21:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KIM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3608114</link>
    </item>
    <item>
      <title>Gabelli &amp; Company Releases The Focus Five</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3597406</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Constellation Brands (NYSE: STZ)&lt;/li&gt;&lt;li&gt;In the three-month period that ended on Friday, October 30, 2009, the Focus   Five increased 9.48% compared to the S&amp;P 500, which rose 4.93%.&lt;/li&gt;&lt;li&gt;Since inception in January 2006, the Focus Five has increased   133.8%, while the S&amp;P 500 has declined 14.6% over the same period.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3597406>[More...]</a>]]></description>
      <pubDate>Mon, 02 Nov 2009 12:04:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">DTV</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GBL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MICC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">STZ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SWY</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3597406</link>
    </item>
    <item>
      <title>Phase Forward Reports Third Quarter 2009 Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3591497</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data   management solutions for clinical trials and drug safety, today   announced its financial results for the third quarter of 2009.&lt;/li&gt;&lt;li&gt;Within total   revenues, electronic data capture (EDC) license, application hosting and   other related revenues were $38.5 million, representing 71% of third   quarter total non-GAAP revenues and an increase of 18% from $32.7   million in the prior year period.&lt;/li&gt;&lt;li&gt;Weiler added, &quot;During the third quarter, a pharmaceutical company in the   top 40 in sales selected Phase Forward's InForm EDC solution for a   multi-year, multi-million dollar commitment, while a leading provider of   information technology, consulting, and business process outsourcing   services selected InForm as part of their outsourcing services to a top   10 pharma.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3591497>[More...]</a>]]></description>
      <pubDate>Thu, 29 Oct 2009 20:51:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFWD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3591497</link>
    </item>
    <item>
      <title>Howard Dean to Speak at the 2009 Mid-Atlantic Bio Conference</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3590187</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Mid-Atlantic Bio today announced that former Vermont Governor Howard   Dean will serve as the closing plenary speaker at the 2009 Mid-Atlantic   Bio Conference, November 4 through 6, held in Washington, D.C., at the   Washington, DC Convention Center. &lt;/li&gt;&lt;li&gt;Additionally, Representative Charles Boustany (R-La.) &lt;/li&gt;&lt;li&gt;Mid-Atlantic Bio is co-hosted by the region's most influential   life science and investor associations, MdBio Division of the Tech   Council of Maryland (TCM/MdBio), the Mid-Atlantic Venture Association   (MAVA), and the Virginia Biotechnology Association (VaBIO).&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3590187>[More...]</a>]]></description>
      <pubDate>Thu, 29 Oct 2009 16:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HGSI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3590187</link>
    </item>
    <item>
      <title>AstraZeneca: Third Quarter and Nine Months Results 2009</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3589901</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;AstraZeneca (STO:AZN) (LSE:AZN)&lt;/li&gt;&lt;li&gt;Third quarter revenue increased by 10 percent at constant exchange rates   (CER) to $8,200 million.&lt;/li&gt;&lt;li&gt;-Emerging Markets revenue was up 15 percent at CER; on track for   double-digit growth for the full year.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3589901>[More...]</a>]]></description>
      <pubDate>Thu, 29 Oct 2009 13:52:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NKTR</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3589901</link>
    </item>
    <item>
      <title>POZEN Reports Third Quarter 2009 Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3586340</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;POZEN Inc. (NASDAQ: POZN), today announced results for the   third quarter ended September 30, 2009.&lt;/li&gt;&lt;li&gt;POZEN reported a net income of $6.7 million, or $0.22 per share on a   diluted basis, for the third quarter of 2009, compared to net loss of   $(7.9) million, or $(0.26) per share on a diluted basis, for the third   quarter of 2008.&lt;/li&gt;&lt;li&gt;Revenue for the third quarter ended September 30, 2008   totaled $11.1 million, resulting from the amortization of upfront   payments received pursuant to the collaboration agreements with   AstraZeneca and GlaxoSmithKline of $3.2 million, $7.5 million of revenue   for development work, and $0.4 million of royalties on sales of Treximet.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3586340>[More...]</a>]]></description>
      <pubDate>Wed, 28 Oct 2009 11:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">POZN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3586340</link>
    </item>
    <item>
      <title>Bristol-Myers Squibb Achieves Strong Sales, Earnings Performance in Third Quarter</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3571548</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Bristol-Myers   Squibb Company (NYSE:BMY) today reported strong sales and earnings   growth for the third quarter 2009.&lt;/li&gt;&lt;li&gt;&quot;The performance in the third quarter of 2009 clearly shows the results   of our outstanding business performance, disciplined financial   management and overall strategic execution,&quot; said James   M. Cornelius, chairman and chief executive officer. &lt;/li&gt;&lt;li&gt;Third Quarter Performance                                                                                                                2009        2008        Change   Net Sales                                           $  5,487    $  5,254    4%       Net Earnings from Continuing Operations             $  966      $  588      64%      GAAP Diluted EPS from Continuing Operations            0.48        0.29     66%      Non-GAAP Diluted EPS from Continuing Operations        0.52        0.45     16%      ($ amounts in millions, except per share amounts)&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3571548>[More...]</a>]]></description>
      <pubDate>Thu, 22 Oct 2009 11:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MJN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3571548</link>
    </item>
    <item>
      <title>Merck Announces Third-Quarter 2009 Financial Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3571555</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Merck &amp; Co., Inc. today announced financial results for the third &lt;/li&gt;&lt;li&gt;Merck &amp; Co., Inc. Consolidated Results (In Millions Except Earnings per Common Share) Quarter Ended September 30 (Unaudited) &lt;/li&gt;&lt;li&gt;The following table shows the financial results for Merck &amp; Co., Inc.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3571555>[More...]</a>]]></description>
      <pubDate>Thu, 22 Oct 2009 11:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3571555</link>
    </item>
    <item>
      <title>Form  4          LOURENSO FRANK            For: Oct 15 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3612079</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3612079>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 21:12:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KIM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3612079</link>
    </item>
    <item>
      <title>Form  4          HUGHES F PATRICK          For: Oct 15 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3612065</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3612065>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 21:05:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KIM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3612065</link>
    </item>
    <item>
      <title>Form  4          GRILLS JOE                For: Oct 15 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3612041</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3612041>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 20:54:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KIM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3612041</link>
    </item>
    <item>
      <title>Form  4          REGENERON PHARMACEUTICAL  For: Oct 29  Filed by: GOLDBERG MURRAY A (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3598965</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3598965>[More...]</a>]]></description>
      <pubDate>Mon, 02 Nov 2009 18:06:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">REGN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3598965</link>
    </item>
    <item>
      <title>Form  4          VOGEL CARL E              For: Sep 30 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3525666</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3525666>[More...]</a>]]></description>
      <pubDate>Sat, 03 Oct 2009 00:58:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">DISH</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3525666</link>
    </item>
    <item>
      <title>Form  4          DISH Network CORP         For: Sep 30  Filed by: ORBAN PAUL W (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3525291</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3525291>[More...]</a>]]></description>
      <pubDate>Fri, 02 Oct 2009 23:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">DISH</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3525291</link>
    </item>
    <item>
      <title>Form  4          CAREY CHASE               For: Sep 21 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3497207</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3497207>[More...]</a>]]></description>
      <pubDate>Tue, 22 Sep 2009 17:24:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">DTV</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3497207</link>
    </item>
    <item>
      <title>Form  4          Vaylet Jean               For: Sep 14 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3486087</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3486087>[More...]</a>]]></description>
      <pubDate>Wed, 16 Sep 2009 22:59:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ATML</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3486087</link>
    </item>
    <item>
      <title>Form  4          McCaman David             For: Sep 14 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3486055</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3486055>[More...]</a>]]></description>
      <pubDate>Wed, 16 Sep 2009 22:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ATML</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3486055</link>
    </item>
    <item>
      <title>Form  4          Reutens Patrick           For: Sep 14 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3486041</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3486041>[More...]</a>]]></description>
      <pubDate>Wed, 16 Sep 2009 22:45:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ATML</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3486041</link>
    </item>
    <atom:link href="http://www.istockanalyst.com/widget/customsymbolfeed.aspx?symbols=ASR,ATML,AZN,DISH,DTV,KIM,REGN,SNY," rel="self" type="application/rss+xml" />
  </channel>
</rss>